Pfizer stock lost nearly half its value over the past couple of years, but some of the world's most successful investors bought millions of shares in the first quarter.
Prominent billionaire investors shockingly sent two premier income stocks to the chopping block in the March-ended quarter, while piling into a monthly dividend payer with a nearly 15% yield.